Normal vitamin D receptor concentration and responsiveness to 1,25-dihydroxyvitamin D3 in skin fibroblasts from patients with absorptive hypercalciuria

Mineral and Electrolyte Metabolism

Volumn 24, Issue 5, 1998, Pages 307-313

  Zerwekh, Joseph E ^a   Reed, Bernice Y ^a   Heller, Howard J ^a   González, Gilberto B ^a   Haussler, Mark R ^b   Pak, Charles Y C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b University of Arizona   (United States)

Author keywords

24 Hydroxylase; Absorptive hypercalciuria; Skin fibroblasts; Vitamin D receptor; Vitamin D receptor mRNA

Indexed keywords

CALCIUM; VITAMIN D; VITAMIN D RECEPTOR;

ADULT; ARTICLE; CALCIUM ABSORPTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERCALCIURIA; IMMUNOBLOTTING; INTESTINE ABSORPTION; MALE; METHODOLOGY; PRIORITY JOURNAL; SKIN FIBROBLAST;

NON-PROGRAMMATIC;

ABSORPTION; ADULT; CALCITRIOL; CALCIUM; CYTOCHROME P-450 ENZYME SYSTEM; FEMALE; FIBROBLASTS; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; OSMOLAR CONCENTRATION; RECEPTORS, CALCITRIOL; REFERENCE VALUES; RNA, MESSENGER; SKIN; STEROID HYDROXYLASES;

EID: 0031827076     PISSN: 03780392     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057388     Document Type: Article

References (33)

1. Pak CYC, Ohata M, Lawrence ED, Snyder W: The hypercalciurias: Causes, parathyroid functions and diagnostic criteria. J Clin Invest 1974;54:387-400.
2. Pak CYC, Britton F, Peterson R, Ward D, Northcutt C, Breslau NA, McGuire J, Sakhaee K, Bush S, Nicar M, Norman DA, Peters P: Ambulatory evaluation of nephrolithiasis: Classification, clinical presentation, and diagnostic criteria. Am J Med 1980;69:19-30.
3. Pietschmann F, Breslau NA, Pak CYC: Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 1992;7:661-667.
4. Kaplan RA, Haussler MR, Deftos LJ, Bone H, Pak CYC: The role of la,25-dihydroxyvitamin D in the mediation of intestinal hyperabsorption of calcium in primary hyperparathyroidism and absorptive hypercalciuria. J Clin Invest 1977;59:756-760.
5. 2 vitamin D levels in humans: Studies in healthy subjects, in calcium-stone formers and in patients with primary hyperparathyroidism. J Clin Endocrinol Metab 1977;45:299-306.
6. Caldas AE, Gray RW, Lemann J Jr: The simultaneous measurement of vitamin D metabolites in plasma: Studies in healthy males and in patients with calcium nephrolithiasis. J Lab Clin Med 1978;91:840-849.
7. Zerwekh JE, Yu S-P, Breslau NA, Manolagas S, Pak CYC: Vitamin D receptor quantitation in human blood mononuclear cells in health and disease. Mol Cell Endocrinol 1993;96:1-6.
8. Zerwekh JE, Hughes MR, Reed BY, Breslau NA, Heller HJ, Lemke M, Nasonkin I, Pak CYC: Evidence for normal vitamin D receptor messenger ribonucleic acid and genotype in absorptive hypercalciuria. J Clin Endocrinol Metab 1995;80:2960-2965.
9. Preminger GM, Peterson RA, Pak CYC: Differentiation of unclassified hypercalciuria utilizing a sodium cellulose phosphate trial; in Walker VR, Sutton RAC, Cameron ECB, Pak CYC, Robertson WG (eds): Urolithiasis. New York, Plenum Press, 1989, pp 325-328.
10. Popoff SN, Osier LK, Zerwekh JE, Marks SC Jr: Interdependence of skeletal sclerosis and elevated circulating levels of 1,25 dihydroxy vitamin D in osteopetrotic (Op and Tl) rats. Bone 1994;15:515-522.
11. Sakhaee K, Baker S, Zerwekh JE, Poindexter J, Garcia-Hemandez PA, Pak CYC: Limited risk of kidney stone formation during long-term calcium citrate supplementation in non-stone forming subjects. J Urol (Paris) 1994;152:324-327.
12. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
13. 3: Immunologic characterization and homogeneous isolation of a 60,000 dalton protein. J Biol Chem 1987;262:1304-1311.
14. 3 hormone: Expression of the human vitamin D receptor in E. coli. J Steroid Biochem Mol Biol 1995;53:583-594.
15. 3. J Clin Invest 1983;72:1190-1199.
16. 3: Isolation, identification, and biological activity. Arch Biochem Biophys 1981;210:103-109.
17. Shen FH, Ivey JL, Sherrard DJ, Nielsen RL, Haussler MR, Baylink DJ: Further evidence supporting the phosphate leak hypothesis of idiopathic hypercalciuria. Adv Exp Med Biol 1978;103:217-223.
18. Insogna KL, Broadus AE, Breyer BE, Ellison AF, Gertner JM: Elevated production rate of 1,25-dihydroxyvitamin D in patients with absorptive hypercalciuria. J Clin Endocrinol Metab 1985;61:490-495.
19. Breslau NA, Preminger GM, Adams BV, Otey J, Pak CYC: Use of ketoconazole to probe the pathogenetic importance of 1,25-dihydroxyvitamin D in absorptive hypercalciuria. J Clin Endocrinol Metab 1992;75:1446-1452.
20. Li XQ, Tembe V, Horowitz GM, Bushinsky DA, Favus MJ: Increased intestinal vitamin D receptor in genetic hypercalciuric rats: A cause of intestinal hyperabsorption. J Clin Invest 1993;91:661-667.
21. 3 receptors in human skin biopsies. J Clin Endocrinol Metab 1980;51:1463-1465.
22. 3 receptors. Science 1984;224: 879-881.
23. Coe FL, Parks JA, Moore ES: Familial idiopathic hypercalciuria. N Engl J Med 1979;300: 337-340.
24. Pak CYC, McGuire J, Peterson R, Britton F, Harold MJ: Familial absorptive hypercalciuria in a large kindred. J Urol 1981;126:717-719.
25. Kim M, Sessler NE, Tembe V, Favus MJ, Bushinsky DA: Response of genetic hypercalciuric rats to a low calcium diet. Kidney Int 1993;43:189-196.
26. 3. J Clin Endocrinol Metab 1982;55:1020-1022.
27. Wiese RJ, Goto H, Prahl JM, Marx SJ, Thomas M, Al-Aqeel A, DeLuca UF: Vitamin D dependent rickets type H: Truncated vitamin D receptor in three kindreds. Mol Cell Endocrinol 1993;90:197-201.
28. 3 results form ligand-induced stabilization. J Biol Chem 1992;267:20082-20086.
29. Santiso-Mere D, Sore T, Hilliard GM IV, Pike JW, McDonnell DP: Positive regulation of the vitamin D receptor by its cognate ligand in heterologous expression systems. Mol Endocrinol 1993;7:833-839.
30. 3. Mol Endocrinol 1993;7: 1307-1312.
31. Yao J, Wong MS, Bushinsky DA, Favus MJ: Altered regulation of calbindin gene expression in genetic hypercalciuric rats. J Bone Miner Res 1996;11(suppl 1):373.
32. 3-1α-hydroxylase; in Pak CYC, Resnick MI, Preminger GM (eds): Urolithiasis 1996. Proc VIIIth Int Symp on Urolithiasis, Dallas. Dallas, Millet, 1996, pp 540-542.
33. Zerwekh JE, Sakhaee K, Breslau NA, Gottschalk F, Pak CYC: Impaired bone formation in male idiopathic osteoporosis: Further reduction in the presence of concomitant hypercalciuria. Osteoporos Int 1992;2:128-134.